0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Snow RW/Lancet
26 results

Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.Asante, K. P. Mathanga, D. P. Milligan, P. Akech, S. Oduro, A. Mwapasa, V. Moore, K. A. Kwambai, T. K. Hamel, M. J. Gyan, T. Westercamp, N. Kapito-Tembo, A. Njuguna, P. Ansong, D. Kariuki, S. Mvalo, T. Snell, P. Schellenberg, D. Welega, P. Otieno, L. Chimala, A. Afari, E. A. Bejon, P. Maleta, K. Agbenyega, T. Snow, R. W. Zulu, M. Chinkhumba, J. Samuels, A. M. Malaria Vaccine Programme Evaluation, Partners
Lancet, (2024). 403:1660-1670

The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity.Noor, A. M. Kinyoki, D. K. Mundia, C. W. Kabaria, C. W. Mutua, J. W. Alegana, V. A. Fall, I. S. Snow, R. W.
Lancet, (2014). 383:1739-47

The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial.Zurovac, D. Sudoi, R. K. Akhwale, W. S. Ndiritu, M. Hamer, D. H. Rowe, A. K. Snow, R. W.
Lancet, (2011). 378:795-803

Call to action: priorities for malaria elimination.Feachem, R. G. Phillips, A. A. Targett, G. A. Snow, R. W.
Lancet, (2010). 376:1517-21

Shrinking the malaria map: progress and prospects.Feachem, R. G. Phillips, A. A. Hwang, J. Cotter, C. Wielgosz, B. Greenwood, B. M. Sabot, O. Rodriguez, M. H. Abeyasinghe, R. R. Ghebreyesus, T. A. Snow, R. W.
Lancet, (2010). 376:1566-78

Operational strategies to achieve and maintain malaria elimination.Moonen, B. Cohen, J. M. Snow, R. W. Slutsker, L. Drakeley, C. Smith, D. L. Abeyasinghe, R. R. Rodriguez, M. H. Maharaj, R. Tanner, M. Targett, G.
Lancet, (2010). 376:1592-603

Ranking of elimination feasibility between malaria-endemic countries.Tatem, A. J. Smith, D. L. Gething, P. W. Kabaria, C. W. Snow, R. W. Hay, S. I.
Lancet, (2010). 376:1579-91

India's invisible malaria burden.Hay, S. I. Gething, P. W. Snow, R. W.
Lancet, (2010). 376:1716-7

Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments.Snow, R. W. Okiro, E. A. Gething, P. W. Atun, R. Hay, S. I.
Lancet, (2010). 376:1409-16

Malaria in Africa: progress and prospects in the decade since the Abuja Declaration.Snow, R. W. Marsh, K.
Lancet, (2010). 376:137-9

Insecticide-treated net coverage in Africa: mapping progress in 2000-07.Noor, A. M. Mutheu, J. J. Tatem, A. J. Hay, S. I. Snow, R. W.
Lancet, (2009). 373:58-67

Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya.O'Meara, W. P. Bejon, P. Mwangi, T. W. Okiro, E. A. Peshu, N. Snow, R. W. Newton, C. R. Marsh, K.
Lancet, (2008). 372:1555-62

Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study.Fegan, G. W. Noor, A. M. Akhwale, W. S. Cousens, S. Snow, R. W.
Lancet, (2007). 370:1035-9

Iron and folic acid supplementation and malaria risk.English, M. Snow, R. W.
Lancet, (2006). 367:90-1

Delivery of paediatric care at the first-referral level in Kenya.English, M. Esamai, F. Wasunna, A. Were, F. Ogutu, B. Wamae, A. Snow, R. W. Peshu, N.
Lancet, (2004). 364:1622-9

Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya.English, M. Esamai, F. Wasunna, A. Were, F. Ogutu, B. Wamae, A. Snow, R. W. Peshu, N.
Lancet, (2004). 363:1948-53

WHO, the Global Fund, and medical malpractice in malaria treatment.White, N. Nosten, F. Bjorkman, A. Marsh, K. Snow, R. W.
Lancet, (2004). 363:1160

Forecasting, warning, and detection of malaria epidemics: a case study.Hay, S. I. Were, E. C. Renshaw, M. Noor, A. M. Ochola, S. A. Olusanmi, I. Alipui, N. Snow, R. W.
Lancet, (2003). 361:1705-6

Will the Global Fund help roll back malaria in Africa?.Teklehaimanot, A. Snow, R. W.
Lancet, (2002). 360:888-9

Sustainability, affordability, and equity of corporate drug donations: the case of Malarone.Shretta, R. Brugha, R. Robb, A. Snow, R. W.
Lancet, (2000). 355:1718-20